Fiercebiotech

Published September 15, 2026 · Updated September 16, 2026

J&J's Contineum-partnered depression drug flunks another phase 2 test - Fierce Biotech

Read the full story at Fiercebiotech

As 'cultural weight' of a psychedelic approval looms, FDA hearing focuses on access and safety. Sep 14, 2026 6:00pm. See more articles. Home.